Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tonix Pharmaceuticals Holding (TNXP) Debt to Equity (2023 - 2024)

Tonix Pharmaceuticals Holding has reported Debt to Equity over the past 2 years, most recently at $0.05 for Q4 2024.

  • Quarterly results put Debt to Equity at $0.05 for Q4 2024, down 36.47% from a year ago — trailing twelve months through Dec 2024 was $0.05 (down 36.47% YoY), and the annual figure for FY2024 was $0.05, down 36.47%.
  • Debt to Equity for Q4 2024 was $0.05 at Tonix Pharmaceuticals Holding, down from $0.11 in the prior quarter.
  • Over the last five years, Debt to Equity for TNXP hit a ceiling of $0.2 in Q2 2024 and a floor of $0.05 in Q4 2024.